Introduction {#s1}
============

Coenzyme A (CoA) is a ubiquitous and essential cofactor in all living cells, where it functions as a carbonyl-activating group and a carrier for activated acyl groups in numerous metabolic and catabolic processes. The biosynthesis of CoA in prokaryotes and eukaryotes is a conserved process that requires pantothenic acid (vitamin B5), cysteine and ATP. The presence of a thiol group in the CoA structure is at the core of its biochemical behavior. In cells, CoA forms a diverse range of thioester derivatives, such as Acetyl CoA, malonyl CoA and 3-hydroxy-3-methylglutaryl (HMG) CoA, which play central roles in many biochemical reactions in protein, carbohydrate and lipid metabolism \[[@BCJ-475-1909C1]--[@BCJ-475-1909C4]\]. These include the synthesis and oxidation of fatty acids, isoprenoid and cholesterol biosynthesis, amino acid metabolism, the Krebs cycle and the synthesis of peptidoglycans. In addition, CoA derivatives function as substrates for protein acylation (e.g. lysine acetylation succinylation, malonylation, propionylation and butyrylation), which has emerged as an important mechanism in the regulation of transcription, chromatin maintenance and cellular metabolism \[[@BCJ-475-1909C5]--[@BCJ-475-1909C7]\].

One aspect of CoA biochemistry that has not been well investigated is the role of this central metabolic coenzyme in thiol-disulfide exchange reactions and redox regulation. It has been reported that CoA undergoes copper-catalyzed air oxidation at a rate which is 4-fold slower than GSH (glutathione) and 720-fold less rapidly than cysteine, making it an appropriate protective thiol in all living cells \[[@BCJ-475-1909C8]\]. As a thiol-containing molecule, CoA has been found to form CoA disulfides (CoASSCoA) and mixed disulfides with other low-molecular-weight (LMW) thiols (e.g, CoA-cysteine and CoA-glutathione, CoASSG) or cysteine residues in specific proteins. The CoASSG heterodimer has been isolated from bacteria, yeast, human myocardial tissue and parathyroid glands \[[@BCJ-475-1909C9]--[@BCJ-475-1909C11]\]. Potent vasoconstrictive and proliferative effects of CoASSG were observed in cultured vascular smooth muscle cells \[[@BCJ-475-1909C12]\]. CoASSG was also shown to inhibit the activity of bacterial RNA polymerase \[[@BCJ-475-1909C13]\].

Exposed protein thiols are the predominant targets of redox-linked regulation mediated by post-translational modifications, including oxidation, S-acylation, S-nitrosation, persulfhydration and S-thiolation \[[@BCJ-475-1909C14],[@BCJ-475-1909C15]\]. When the cysteine thiol group is oxidized by reactive oxygen species (ROS) to an unstable sulfenic acid intermediate, it can react with nearby thiols leading to the formation of intra- and intermolecular disulfides or mixed disulfides with LMW thiols, such as cysteine, glutathione, bacillithiol and CoA. Formed disulfides are reversible regulatory events and function to protect unstable sulfenic acids against overoxidation to sulfinic and sulfonic acids which may alter irreversibly the structure, function and subcellular localization of modified proteins \[[@BCJ-475-1909C16]\].

The formation of mixed disulfides between CoA and cysteines of specific proteins has been reported in several biochemical and crystallographic studies \[[@BCJ-475-1909C17]--[@BCJ-475-1909C21]\]. The CoA-modified forms of acetyl-CoA acetyltransferase and glutamate dehydrogenase were detected immunohistochemically in rat liver mitochondria \[[@BCJ-475-1909C17],[@BCJ-475-1909C18]\]. In these studies, the activity and half-life of acetyl-CoA acetyltransferase were shown to be modified by covalent attachment of CoA. Furthermore, covalent modification of phenol sulfotransferase by CoA was shown to inhibit its activity in a dose- and time-dependent manner \[[@BCJ-475-1909C19]\]. In *Klebsiella pneumoniae*, CoA binding to flavodoxin NifF was found to halt the N~2~ fixation by blocking electron transfer from pyruvate-flavodoxin oxidoreductase NifJ to nitrogenase NifH \[[@BCJ-475-1909C20]\]. Covalent binding of CoA to the *Bacillus subtilis* organic peroxide sensor OhrR was reported, but the consequence of this modification on the transcription repressor activity of OhrR in oxidative stress response has not been examined \[[@BCJ-475-1909C21]\]. Despite the existence of these sporadic studies, investigation into the extent of covalent protein modification by CoA and the mechanism of regulation in eukaryotes and prokaryotes has long been overdue. Recent studies from our laboratory revealed extensive covalent modification of cellular proteins by CoA in mammalian cells and tissues, which we termed protein CoAlation \[[@BCJ-475-1909C22]\]. We showed that protein CoAlation is a reversible post-translational modification induced in mammalian cells by oxidizing agents and metabolic stress. To uncover protein CoAlation as a common post-translational modification and to reveal its role in redox regulation, we have developed a range of new research tools and methodologies, including: (a) unique anti-CoA mAbs which work efficiently in various immunological assays; (b) *in vitro* protein CoAlation and assay and (c) a reliable strategy for the identification of CoAlated proteins by LC--MS/MS.

In the present paper, we provide evidence that protein CoAlation occurs at a low level in Gram-negative and Gram-positive bacteria under normal growth conditions, but is strongly induced in response to oxidizing agents and metabolic stress. Approximately 12% of the predicted *Staphylococcus aureus* proteome was found to be CoAlated in diamide-treated bacteria. SaGAPDH (*S. aureus* glyceraldehyde-3-phosphate dehydrogenase), a key enzyme in glycolysis, was found to be readily CoAlated in *Escherichia coli* treated with hydrogen peroxide (H~2~O~2~), diamide and sodium hypochlorite (NaOCl). Furthermore, *in vitro* CoAlation of recombinant SaGAPDH prevented overoxidation and irreversible loss of its activity in the presence of exogenous H~2~O~2~. Altogether, our findings suggest that in bacteria, protein CoAlation is a widespread redox-regulated post-translational modification with a potential to protect critical reactive cysteines against irreversible overoxidation.

Experimental {#s2}
============

Reagents and chemicals {#s2a}
----------------------

All common chemicals were obtained from Sigma--Aldrich unless otherwise stated. The generation and characterization of the anti-CoA antibody (1F10) was described recently \[[@BCJ-475-1909C23]\]. For Western blotting, anti-CoA antibody was diluted in Odyssey blocking buffer (0.17 µg/ml) containing 0.01% Tween 20. Secondary antibodies \[Alexa Fluor 680 goat antimouse IgG H&L (Life Technologies)\] were diluted in Odyssey blocking buffer (1 : 10 000) containing 0.02% sodium dodecyl sulfate (SDS).

Bacterial species, growth conditions and treatments {#s2b}
---------------------------------------------------

Following bacterial species were used in the present study: *E. coli* SG13009 and DH5alpha, *Bacillus megaterium* NCTC10342 and *S. aureus* DSM11729. *B. megaterium* cells were cultured overnight in Nutrient Broth 3 (NB3) medium, while *E. coli* and *S. aureus* cells were grown in Luria Bertani (LB) medium. The overnight cultures were diluted 1 : 100 in the same media and incubated until the optical density of 0.7 at 600 nm (OD~600~). The samples of cells were then treated with or without oxidizing agents for 30 min at 37°C: hydrogen peroxide (10 and 100 mM), diamide (2 mM) and NaOCl (150 µM). To induce metabolic stress, bacterial cultures at OD~600~ of 0.7 were harvested by centrifugation and resuspended in M9 minimal medium supplemented with or without glucose as a source of carbohydrate.

Cell lysis and protein extraction {#s2c}
---------------------------------

Protein extracts from harvested bacteria were prepared in the following ways: (a) the pellet of harvested *E. coli*, *B. megaterium* and *S. aureus* was resuspended in buffer containing 100 mM Tris--HCl, pH 7.5, 100 mM NaCl, 100 mM NEM and a cocktail of protease inhibitors (Roche). SDS was added (1% final), and the homogenate was sonicated to reduce viscosity before centrifuging at 21 000 ***g*** for 10 min at RT. The supernatant was collected and analyzed by western blotting. (b) The pellet of harvested *S. aureus* was resuspended in buffer containing 100 mM Tris--HCl, pH 7.5, 100 mM NaCl, 100 mM NEM and a cocktail of protease inhibitors (Roche). To solubilize cell wall proteins, lysostaphin (22 U/ml) was added and the lysate was incubated at 37°C for 30 min. After the addition of SDS (1% final), the homogenate was sonicated to reduce viscosity before centrifuging at 21 000 ***g*** for 10 min at RT. The supernatant was collected for further analysis.

Western blot analysis {#s2d}
---------------------

Samples of bacterial extracts containing ∼30--40 µg of proteins were heated for 5 min at 99°C in SDS loading buffer with or without dithiothreitol (DTT, 100 mM final) and separated by SDS--polyacrylamide gel electrophoresis (PAGE) on 4--20% Mini-PROTEAN TGX Precast Gels (Bio-Rad Laboratories). Separated proteins were transferred from the gel to a low-fluorescence polyvinylidene fluoride membrane (Bio-Rad Laboratories), which was then blocked with Odyssey blocking buffer (LI-COR Biosciences). Primary anti-CoA antibody was diluted in Odyssey blocking buffer (0.17 µg/ml) and incubated with the membrane for 2 h at RT or overnight at 4°C. Immunoreactive protein bands were visualized using infrared dye-conjugated secondary antibodies and the Odyssey infrared imaging system (Odyssey Scanner CLx and Image Studio Lite software, LI-COR Biosciences).

Expression and affinity purification of SaGAPDH {#s2e}
-----------------------------------------------

The full coding sequence of SaGAPDH was cloned into the pQE3/SaGAPDH expression plasmid with the N-terminal His-tag sequences as previously described \[[@BCJ-475-1909C24]\]. Expression of His-tagged SaGAPDH was carried out in exponentially growing SG13009 cells in the presence of 1 mM isopropyl- β-[d]{.smallcaps}-thiogalactopyranoside (IPTG). After 3 h induction at 37°C, the cells were harvested and stored at −80°C. Affinity purification of His-tagged SaGAPDH was performed using Ni-NTA chromatography. Eluted preparations were examined by SDS--PAGE and stored at −80°C.

GAPDH enzymatic assay {#s2f}
---------------------

Recombinant SaGAPDH activity was determined by measuring the absorbance change at 340 nm and 25°C resulting from the production of NADH. The reaction was carried out in a 150 µl assay mixture containing 20 mM Tris--HCl (pH 8.7), 0.36 µM SaGAPDH, 1.25 mM NAD^+^, 1.25 mM ethylenediaminetetraacetic acid and 15 mM sodium arsenate. The reaction was started by the addition of 0.25 mM glyceraldehyde 3-phosphate. Initial reaction rates were calculated as described recently \[[@BCJ-475-1909C25]\], by determining the slope in the linear part of the curve during the first 80 s of the reaction (GraphPad, linear regression function). The percentage of SaGAPDH activity was calculated as: Rate of inactivated/Rate of untreated × 100%. The results are presented as mean ± SEM from at least three separate experiments.

For the inactivation experiments, SaGAPDH was preincubated with 1 µM, 10 µM, 100 µM and 10 mM H~2~O~2~ for 10 min or with 10 mM CoASSCoA for 30 min. About 2 µl of the mixture was then added to the assay mixture and the remaining activity was measured as described. To reduce it, the enzyme was incubated with 10 mM DTT for 15 min. After treatments, excess H~2~O~2~, CoASSCoA and DTT were removed using Micro Biospin 6 columns (Bio-Rad).

Purification and activity assay of Nudix 7 hydrolase {#s2g}
----------------------------------------------------

Recombinant His-Nudix 7 hydrolase was expressed in bacteria and purified by Ni-NTA affinity chromatography. His-Nudix 7 (1.7 µg) was incubated in a total volume of 100 µl containing 50 mM (NH~4~)HCO and 0.2 mM CoASSG at 37°C for 20 min with or without 5 mM MgCl~2~. Reaction products and substrates were analyzed by HPLC as described, except that elution was monitored at 205 nm \[[@BCJ-475-1909C26]\].

Preparation and enrichment of CoAlated peptides from diamide-treated *S. aureus* for MS analysis {#s2h}
------------------------------------------------------------------------------------------------

The pellet of diamide-treated *S. aureus* (2 mM for 30 min) was resuspended in buffer containing 100 mM Tris--HCl, pH 7.5, 100 mM NaCl, 100 mM NEM and a cocktail of protease inhibitors (Roche). The lysate was incubated with lysostaphin (20 U/ml) at 37°C for 30 min to solubilize cell wall proteins. SDS was then added (1% final), and the homogenate was sonicated to reduce viscosity before centrifuging at 21 000 ***g*** for 10 min at RT. Proteins in the supernatant were precipitated with 90% methanol. The protein pellet was resuspended in 50 mM (NH~4~)HCO~3~ (pH 7.8) supplemented with 6.4 mM iodoacetamide (IAM) and digested with endoproteinases Lys C and trypsin (sequencing grade, Promega). After heat inactivation (99°C, 10 min) of digestive enzymes, CoAlated peptides were immunoprecipitated with anti-CoA antibody cross-linked to Protein G Sepharose. Trypsin digested and immunoprecipitated peptide mixtures were dried down completely in a SpeedVac and resolubilized in 20 µl of 50 mM ammonium bicarbonate (Ambic). After mixing for 2 min, 2.3 µl of 50 mM MgCl~2~ was added followed by 1 µl of Nudix 7 phosphatase. The solution was incubated at 37°C for 20 min then acidified, desalted with a C~18~ Stage tip that contained 1.5 µl of Poros R3 resin and partially dried in a SpeedVac. Modified peptides were further enriched using Phos-Select IMAC resin (Sigma). Desalted peptides were resuspended in 100 µl of 30% MeCN, 0.25 M acetic acid (loading solution) and 30 µl of IMAC beads, previously equilibrated with the loading solution was added. After 45 min incubation at room temperature, beads were washed four times with loading solution and CoAlated peptides were eluted twice with 500 mM imidazole (pH 7.6) and once with 30% MeCN/500 mM imidazole (pH 7.6). CoAlated peptides were acidified, dried and desalted with a C18 Stage tip that contained 1.5 µl of Poros R3 resin. This solution was then partially dried down using a SpeedVac and was ready for mass spectrometry analysis.

*In vitro* CoAlation of SaGAPDH {#s2i}
-------------------------------

About 100 µg of affinity-purified SaGAPDH was CoAlated in buffer containing 50 mM Tris-HCl, pH 7.5 and 250 µM CoASSCoA for 30 min. Excess of unbound CoASSCoA was removed using Micro Biospin 6 columns (Bio-Rad).

Preparation and enrichment of CoAlated peptides from *in vitro* CoAlated SaGAPDH {#s2j}
--------------------------------------------------------------------------------

Solution samples of *in vitro* CoAlated SaGAPDH (2 µg) in 50 mM ammonium bicarbonate (NH~4~CO~3~) and 8 mM iodoacetamide were digested with endoproteinases Lys C and elastase (Promega, U.K.). To the peptide mixture, 3.1 µl of 50 mM MgCl~2~ was added followed by 1.35 µl of Nudix-7 phosphatase and the mixture was incubated at 37°C for 20 min. The peptide mixture was then acidified, desalted on a C18 Stage tip (3M Empore) containing 0.7 µl of Poros R3 resin (Applied Biosystems, U.K.) and partially dried in a SpeedVac.

CoAlated peptides were enriched using Phos-Select IMAC resin (Sigma, U.K.). Desalted peptides were resuspended in 100 µl of 30% (v/v) acetonitrile (MeCN), 0.25 M acetic acid (loading solution) and 10 µl of IMAC resin, previously equilibrated with the loading solution was added. After 45 min incubation at room temperature, the resin was washed four times with loading solution and the CoAlated peptides were eluted with 500 mM imidazole (pH 7.6) followed by 30% (v/v) MeCN/500 mM imidazole (pH 7.6). CoAlated peptides were acidified, dried and desalted with a C18 Stage tip containing 0.5 µl of Poros R3 resin (Applied Biosystems, U.K.). The solution was then partially dried down using a SpeedVac prior to analysis by mass spectrometry.

Mass spectrometry and data acquisition {#s2k}
--------------------------------------

Mass spectrometry data acquisition liquid chromatography was performed on a fully automated Ultimate U3000 Nano LC System (Dionex) fitted with a 100 µm × 2 cm PepMap100 C~18~ Nano-Trap column and a 75 μm × 25 cm reverse-phase PepMap100 C~18~ Nano-Trap column (Dionex). Peptides were separated using an acetonitrile gradient and sprayed directly via a nano-flow electrospray ionization source into the mass spectrometer (Orbitrap Velos, Thermo Scientific). The mass spectrometer was operated in a standard data-dependent mode, performed survey full scan (*m*/*z* = 350--1600) in the Orbitrap analyzer, with a resolution of 60 000 at *m*/*z* = 400, followed by MS/MS acquisitions of the 20 most intense ions in the LTQ ion trap. Maximum FTMS scan accumulation times were set at 250 ms and maximum ion trap MSn scan accumulation times were set at 200 ms. The Orbitrap measurements were internally calibrated using the lock mass of polydimethylcyclosiloxane at *m*/*z* 445.120025. Dynamic exclusion was set for 30 s with exclusion list of 500.

Data processing {#s2l}
---------------

LC--MS/MS raw data files were processed as standard samples using MaxQuant version 1.5.2.8, which incorporates the Andromeda search \[[@BCJ-475-1909C27]\]. MaxQuant processed data were searched against a Uniprot --- *S. aureus* (November 2015) database. Carbamidomethyl cysteine, acetyl N-terminal, *N*-ethylmaleimide cysteine, oxidation of methionines, CoAlation of cysteine with *λ* mass 338, 356 and 765 were set as variable modifications. For all data sets, the default parameters in MaxQuant were used, except MS/MS tolerance which was set at 0.6 Da and the second peptide ID was unselected.

Using MQ viewer, CoA_356 peptides were first visually checked. Those matched MS/MS spectra that did not have continuous 4 *y* or *b* ion series were checked manually.

Functional characterization of identified proteins {#s2m}
--------------------------------------------------

Gene ontology (GO) \[[@BCJ-475-1909C28]\] terms describing the function(s) of the identified proteins were either extracted from UniProtKB (UniProt Release June 2017) or predicted using a protein domain-based function prediction pipeline \[[@BCJ-475-1909C29],[@BCJ-475-1909C30]\]. The functions of the proteins were then classified into major functional categories and protein classes were based on the inferred GO terms.

Molecular dynamics simulations {#s2n}
------------------------------

A high-resolution (1.7 Å) X-ray crystal structure of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) complexed with NAD^+^, from *S. aureus*, was obtained from the Protein DataBank (PDBID: 3LVF). Missing residues were modeled with MODELER \[[@BCJ-475-1909C31]\]. The molecular dynamics (MD) simulations were performed using the code GROMACS 4 \[[@BCJ-475-1909C32]\]. To enhance the sampling, we used the Metadynamics algorithm as implemented the PLUMED plug-in \[[@BCJ-475-1909C33],[@BCJ-475-1909C34]\]. The protein was described by the Amber99SB\*-ILDN force field which includes the dihedral corrections of Best and Hummer, while CoA was parametrized with the general Amber force field (GAFF) and RESP charges derived from *ab initio* calculations at the Hartree--Fock level of theory \[[@BCJ-475-1909C35],[@BCJ-475-1909C36]\]. The system was solvated with ∼19 000 tip3p water molecules and enclosed in a dodecahedron box with periodic boundary conditions for a total of more than 60 000 atoms. The van der Waals interactions were smoothly shifted to zero between 0.8 and 1.0 nm; the long-range electrostatic interactions were calculated by the particle mesh Ewald algorithm, with mesh spaced 0.12 nm, combined with a switch function for the direct space between 0.8 and 1.0 nm for better energy conservation \[[@BCJ-475-1909C37],[@BCJ-475-1909C38]\]. Following an initial conjugate gradient optimization to relax the structure and remove possible atomic clashes, a brief NPT equilibration was run with a Berendsen thermostat and target pressure of 1 bar. The system evolved in the canonical ensemble with a time step of 2 fs and was coupled with a velocity-rescale thermostat to maintain the temperature at 300 K.

Statistical analysis {#s2o}
--------------------

Where appropriate, values are given as means ± SEM. Graphs were produced and statistics were calculated using GraphPad Prism (version 6.07 for Windows, GraphPad Software, La Jolla, CA, U.S.A.; [www.graphpad.com](www.graphpad.com)).

Results {#s3}
=======

Oxidizing agents induce strong protein CoAlation in bacteria {#s3a}
------------------------------------------------------------

Bacteria employ a diverse range of molecular mechanisms to cope with ROS/reactive nitrogen species and to repair the resulting damage \[[@BCJ-475-1909C39]\]. These include the production of antioxidant enzymes (superoxide dismutase, catalases and peroxiredoxins) and LMW thiols (glutathione, bacillithiol and mycothiol). While significant progress has been made to understand the antioxidant function of glutathione and to some extent bacillithiol and mycothiol, the role of the small thiol CoA in redox regulation in bacteria remains to be elucidated. This was mainly due to the lack of specific antibodies which can recognize CoA in various immunological assays and a reliable mass spectrometry-based protocol for identifying CoA-modified peptides in CoAlated proteins. The developed research tools and methodologies and the identification of extensive protein CoAlation in mammalian cells induced by oxidizing agents and metabolic stress prompted us to investigate the magnitude and relevance of this post-translational modification in bacteria \[[@BCJ-475-1909C22]\]. To do so, we used both Gram-negative (*E. coli*) and Gram-positive (*S. aureus* and *B. megaterium*) bacteria, which have different expression profiles of LMW thiols. In Gram-negative bacteria and eukaryotes, glutathione is the major LMW thiol and antioxidant; however, it is absent in most Gram-positive bacteria. Instead, the differential expression of bacillithiol and mycothiol has been reported in different species of Gram-positive bacteria, where they function as a thiol redox buffer in the detoxification of ROS, toxins and antibiotics \[[@BCJ-475-1909C40]\]. In contrast, CoA is a ubiquitous and highly expressed LMW thiol in all living cells, whose function has been mainly associated with the regulation of cellular metabolism and gene expression.

Initially, we examined the effect of H~2~O~2~ on protein CoAlation in *E. coli*, *B. megaterium* and *S. aureus*. Here, bacteria were grown to mid-log phase (OD~600~ = 0.7) in rich medium (LB medium for *E. coli* and *S. aureus*; NB3 medium for *B. megaterium*) at 37°C and then treated with and without 10 or 100 mM H~2~O~2~. After 30 min, cells were collected and bacterial protein extracts were prepared as described in the Experimental procedures. Separation of protein extracts under non-reducing conditions and Western blot analysis with anti-CoA antibody 1F10 revealed a weak immunoreactive signal in control samples and cells treated with 10 mM H~2~O~2~ ([Figure 1A](#BCJ-475-1909F1){ref-type="fig"}). However, exposure of cells to 100 mM H~2~O~2~ induced readily detectable protein CoAlation in all three bacterial species. These data indicate that bacteria can cope efficiently with oxidative stress induced by 10 mM H~2~O~2~, without engaging CoA in the antioxidant response. We also observed extensive protein CoAlation in cells treated with the disulfide stress inducer diamide at a concentration of 2 mM. Notably, the pattern of CoA-modified proteins in cells treated with H~2~O~2~ and diamide was similar except for several differentially CoAlated proteins ([Figure 1A](#BCJ-475-1909F1){ref-type="fig"}). Hypochlorous acid (HOCl) is produced by neutrophils to kill engulfed bacteria and is commonly used as an antimicrobial disinfectant \[[@BCJ-475-1909C41]\]. The bactericidal effect of HOCl is associated with the production of various ROS. LMW thiols, such as GSH, protect bacteria from HOCl by direct interaction and the formation of less harmful substances. The treatment of bacteria with NaOCl was shown to induce the formation of mixed disulfides between LMW thiols and proteins, mediated by the disulfide exchange mechanism \[[@BCJ-475-1909C25],[@BCJ-475-1909C42]\]. The treatment of exponentially growing bacteria with 100 µM NaOCl showed the strongest induction of protein CoAlation, when compared with control, H~2~O~2~ or diamide. The pattern of protein CoAlation differed significantly from that of H~2~O~2~- or diamide-treated cells. Ponceau staining of protein blots revealed that the treatment of cells with 100 µM NaOCl caused a significant change in the pattern of separated proteins, when compared with control and H~2~O~2~- or diamide-treated cells ([Figure 1A](#BCJ-475-1909F1){ref-type="fig"}). Figure 1.Induction of protein CoAlation in bacteria by a panel of oxidizing agents.Protein CoAlation in Gram-positive and Gram-negative bacteria is induced by different oxidizing agents (**A**) in a DTT-sensitive manner (**B**). *E. coli*, *B. megaterium* and *S. aureus* were grown to mid-log phase in rich medium at 37°C and then treated for 30 min with and without 10 mM or 100 mM H~2~O~2~, 2 mM diamide and 100 µM NaOCl. Cells were lysed as described in Experimental procedures and protein CoAlation examined by anti-CoA immunoblot. DTT (200 mM final) was added to protein extracts before SDS--PAGE analysis to demonstrate that the protein-CoA binding involves a reversible disulfide bond formation.

To demonstrate that the protein-CoA binding involves a reversible disulfide bond formation, the disulfide reducing agent DTT was added to protein extracts before SDS--PAGE analysis. As shown in [Figure 1B](#BCJ-475-1909F1){ref-type="fig"}, the presence of 200 mM DTT in the sample buffer efficiently abrogated immunoreactive signal in H~2~O~2~- and diamide-treated cells. In case of hypochlorite stress, the reduction of protein-CoA disulfide bonds was not complete and possibly required a higher DTT concentration in the sample buffer.

To find out whether protein CoAlation is a reversible post-translational modification, exponentially growing *E. coli*, *B. megaterium* and *S. aureus* were treated with 2 mM diamide for 30 min. Bacteria were harvested by centrifugation and then incubated in fresh LB or NB3 media for various periods of time to recover from the oxidative stress. As shown in [Figure 2](#BCJ-475-1909F2){ref-type="fig"}, diamide-induced protein CoAlation in *E. coli* was reversed to the level of untreated cells in a time-dependent manner. The reversibility of protein CoAlation in *B. megaterium* and *S. aureus* also occurred in a time-dependent manner, but did not reach baseline levels within 60 min. Figure 2.Diamide-induced protein CoAlation in *E. coli, B. megaterium* and *S. aureus* is a reversible post-translational modification.Exponentially growing bacteria were treated with 2 mM diamide for 30 min. The medium was then replaced with fresh media without the oxidant and cells were incubated for the indicated times. Protein CoAlation was examined by anti-CoA immunoblot.

Induction of protein CoAlation by glucose deprivation {#s3b}
-----------------------------------------------------

Bacteria have evolved elaborate strategies that enable them to adapt to challenging growth environments. When the nutrient supply becomes limiting, bacteria employ general starvation-response mechanisms, such as the stringent response and carbon catabolite repression, which are associated with ROS production and oxidative stress \[[@BCJ-475-1909C43]\]. We were interested to examine whether under nutrient deprivation CoA is also used for S-thiolation of redox-sensitive cysteine residues, resulting in the formation of mixed disulfides with proteins. Taking into account that the examined bacterial species use carbon catabolism for energy generation, we employed the model of glucose starvation.

In the present study, all three types of bacteria were cultured in nutrient-rich medium until OD~600~ = 0.7 and then transferred in the medium lacking glucose or any other source of carbohydrates. As shown in [Figure 3](#BCJ-475-1909F3){ref-type="fig"}, protein CoAlation was at a very low level in bacteria cultured in nutrient-rich medium, but strongly induced under the condition of glucose starvation for 60 and 120 min. The pattern of CoAlated proteins in glucose-starved *E. coli* and *B. megaterium* was similar, but differed significantly from that in *S. aureus*. Comparing the pattern of CoA-modified proteins induced by glucose starvation and the treatment with oxidizing agents revealed little similarity in all three types of examined bacteria, indicating the involvement of different redox-sensing and responding strategies. Figure 3.Induction of protein CoAlation by metabolic stress.Glucose depravation induces protein CoAlation in *E. coli*, *B. megaterium* and *S. aureus*, which is reversed by the re-addition of glucose. *E. coli*, *B. megaterium* and *S. aureus* were grown to mid-log phase in rich medium at 37°C and then transferred and cultured in the medium lacking glucose or any other source of carbohydrates for the indicated times. The cultures of glucose-starved bacteria were then supplemented with 20 mM glucose and incubated at 37°C for 30 min. Protein CoAlation in total protein extracts was examined by anti-CoA immunoblot.

We then examined whether protein CoAlation induced by glucose starvation can be reversed with the re-addition of glucose to starved bacterial cultures. The results presented in [Figure 3](#BCJ-475-1909F3){ref-type="fig"} clearly indicate that supplementing cultures of glucose-starved bacteria with glucose for 30 min resulted in near complete deCoAlation of CoA-modified proteins.

Mass spectrometry-based identification of CoAlated proteins in diamide-treated *S. aureus* {#s3c}
------------------------------------------------------------------------------------------

Extensive protein CoAlation which we observed in Gram-negative and Gram-positive bacteria in response to oxidative and metabolic stress encouraged us to identify CoA-modified proteins using the developed methodology \[[@BCJ-475-1909C22]\]. Our efforts were focused on determining the identity of CoAlated proteins in *S. aureus* under diamide-induced disulfide stress. Exponentially growing *S. aureus* were treated with 2 mM diamide for 30 min and protein extracts were prepared as described in Experimental procedures. In brief, to prevent *in vitro* modification of protein thiols by free CoA, 25 mM NEM was added to the lysis buffer. Extracted proteins were digested with Lys C/trypsin in the presence of IAM and CoAlated peptides were immunoprecipitated with anti-CoA antibody. Then, immune complexes were incubated with Nudix 7 hydrolase to remove the ADP moiety of CoA and to produce a distinctive MS/MS fragmentation signature of Cys + 356, corresponding to covalently attached 4PP (4′-phosphopantetheine). Representative MS/MS spectrum of a cysteine-containing peptide from SaGAPDH is shown in [Figure 4A](#BCJ-475-1909F4){ref-type="fig"}. In total, the LC--MS/MS analysis revealed the identity of 440 CoAlated cysteine-containing peptides which correspond to 356 proteins in the *S. aureus* proteome ([Table 1](#BCJ-475-1909TB1){ref-type="table"}). Bioinformatic pathway analysis revealed that a large number of CoAlated proteins are involved in major metabolic pathways, regulation of transcription, protein synthesis and stress response ([Figure 4B](#BCJ-475-1909F4){ref-type="fig"}). Among identified proteins, we found those which use CoA as the covalent intermediate in catalytic reactions or function as CoA-regulated proteins. These include succinate-CoA ligase, acyl-CoA ligase, HMG-CoA synthase, an acetyl-CoA carboxylase and acyl-CoA dehydrogenase. Figure 4.Development of methodology and the identification of CoAlated proteins.(**A**) Strategy for the identification of CoA-modified proteins *S. aureus* in response to diamide. (**B**) Pie chart showing the major functional categories of the proteins that were identified to be CoAlated in diamide-treated *S. aureus*. Table 1Proteomic identification of CoAlated proteins in *S. aureus* treated with diamide. CoAlated peptides identified by MS/MS analysis and corresponding proteins are shown. Perspective CoA-modified cysteine residues within the identified peptides are marked by asterisks.Gene nameProtein nameMW (kDa)SequenceScoreHMPREF0769_11633Resolvase, N-terminal domain protein21.845LNAYGC\*EK72.531MW2460MW2460 protein63.757LC\*EDVAVYNHQIEK97.291ybaKCys-tRNA(Pro)/Cys-tRNA(Cys) deacylase17.89GGC\*SPVGMK41.689pyrEOrotate phosphoribosyltransferase22.057SPIYC\*DNR105.25binLBinL protein22.491LNTHGC\*EK98.156SAOUHSC_02733Membrane protein, putative67.572NVNVC\*TIPFK116.98SAUSA300_1090Pseudouridine synthase34.634DYTLVEC\*QLETGR88.803SAKOR_01553Uncharacterized protein50.22LIEESPC\*AALTEER106.87pyrGCytidine 5′-triphosphate synthase59.991ESVIEC\*R131.12pyrGCytidine 5′-triphosphate synthase59.991IALFC\*DINK153.34pyrGCytidine 5′-triphosphate synthase59.991LGLYPC\*SIK86.114yisKFumarylacetoacetate hydrolase family protein33.113SLTGGC\*PMGPYIVTK108.45deoC2Deoxyribose-phosphate aldolase 223.341SVC\*VNPTHVK99.941polCDNA polymerase III PolC-type162.69NC\*GFDIDK94.767AYM28_04315Phage protein10.633ENYFC\*DR58.132V070_02571Uncharacterized protein13.806SC\*VEVAR83.647pflBFormate acetyltransferase84.861AAC\*EAYGYELDEETEK166.57pflBFormate acetyltransferase84.861IPYDC\*C\*K101.46rpmF50S ribosomal protein L326.48NC\*GSYNGEEVAAK159.4purBAdenylosuccinate lyase49.603EELDEC\*FDPK109.15pheTPhenylalanine--tRNA ligase β subunit88.901AC\*YLLQTYANGK110.22SAZ172_1072Uncharacterized protein8.7688NAGKFEETPC\*EFVDGSKGVR236.03ddl[d]{.smallcaps}-alanine--[d]{.smallcaps}-alanine ligase40.23ATDC\*SGLVR136.81ddl[d]{.smallcaps}-alanine--[d]{.smallcaps}-alanine ligase40.23C\*NNEAELK100.09HMPREF0769_11996Response regulator receiver domain protein27.021KDGIDVC\*K104.94gapA2Glyceraldehyde-3-phosphate dehydrogenase 236.979SC\*NESIIPTSTGAAK122.83N/ATruncated catalase-like protein38.88GVGIENIC\*PFSR173.19mvaDMevalonate diphosphate decarboxylase36.831EAGYPC\*YFTMDAGPNVK116.79rpoCDNA-directed RNA polymerase subunit β′135.41C\*GVEVTK114.89rpoCDNA-directed RNA polymerase subunit β′135.41DGLFC\*ER87.806rpoCDNA-directed RNA polymerase subunit β′135.41DWEC\*.SC\*.GK121.61rpoCDNA-directed RNA polymerase subunit β′135.41MYQC\*GLPK123.86gluDNAD-specific glutamate dehydrogenase45.76C\*GIVNLPYGGGK135.81gluDNAD-specific glutamate dehydrogenase45.76GGIVC\*DPR110.53SAKOR_01005Phosphoenolpyruvate--protein phosphotransferase63.276LC\*LAQQDIFR135.02SAKOR_02109Uncharacterized protein12.497TAETNYFWLNC\*GYNR141.34HMPREF0776_2410ABC transporter, ATP-binding protein13.659FTEGNC\*YGLIGANGAGK128.85SAOUHSC_00756Uncharacterized protein41.797IAELC\*HK96.034yloUGeneral stress protein, Gls24 family13.345AVEC\*YGIVGMASR161.48rap50S ribosomal protein L230.026MILSTC\*R128.6cmkCytidylate kinase24.595GQC\*VILDNEDVTDFLR91.622sarSHTH-type transcriptional regulator SarS29.889KIVSDLC\*YK205.53SAR2771UPF0176 protein SAR277136.938DWFDGKPC\*ER108.32SAR2771UPF0176 protein SAR277136.938VVTYC\*TGGIR139.78SAR2771UPF0176 protein SAR277136.938YINCANPEC\*NK111.07SAR2771UPF0176 protein SAR277136.938YLGAC\*SYDCAK92.151SAR2771UPF0176 protein SAR277136.938YLGACSYDC\*AK104.7SAR2771UPF0176 protein SAR277136.938YTTIDDPEQFAQDHLAFC\*K97.823HMPREF0769_10405Metallo-β-lactamase domain protein29.57EVLLC\*DTDK190.66ctsRTranscriptional regulator CtsR17.841FDC\*VPSQLNYVIK189.52rplN50S ribosomal protein L1413.135FDENAC\*VIIR96.464rplN50S ribosomal protein L1413.135TANIGDVIVC\*TVK196.01RK97_03585Nitrogen fixation protein NifU16.631C\*ATLAWK95.81RK97_03585Nitrogen fixation protein NifU16.631GVLDNGSMTVDMNNPTC\*GDR109.28proCPyrroline-5-carboxylate reductase29.825QQLEC\*QNPVAR108.23aspSAspartate--tRNA ligase55.836C\*FRDEDLR94.767infBTranslation initiation factor IF-231.699VGTIAGC\*YVTEGK132.15pyrBAspartate carbamoyltransferase33.257GESLYDTC\*K130.69tsaDtRNA N6-adenosine threonylcarbamoyltransferase37.069QSLADQC\*K72.289mshBBacillithiol biosynthesis deacetylase BshB224.894ERELEEAC\*K158.76SAOUHSC_00547Uncharacterized protein58.418QC\*QDISQYIENK94.309murIGlutamate racemase29.702C\*PYGPRPGEQVK103.13clpCATP-dependent Clp protease91.141GELQC\*IGATTLDEYRK190.1SAV0414Uncharacterized protein83.287C\*AIVTDLDEQAIPSEHR77.668SAV0414Uncharacterized protein83.287IVEFEAC\*R149.94SAV0414Uncharacterized protein83.287SNLNFC\*INENYDK231.38murEUDP-*N*-acetylmuramoyl-[l]{.smallcaps}-alanyl-[d]{.smallcaps}-glutamate--[l]{.smallcaps}-lysine ligase54.104FC\*QNVADQGCK82.515SAOUHSC_02158Uncharacterized protein48.119IAFSC\*VEK131.42ribH6,7-Dimethyl-8-ribityllumazine synthase16.41GATSHYDYVC\*NEVAK54.094nadENH(3)-dependent NAD(+) synthetase30.682EEGIDC\*TFIAVK139.77glyASerine hydroxymethyltransferase45.172EAEETLDSVGITC\*NK114.55glyASerine hydroxymethyltransferase45.172GGMILC\*K85.212AYM28_08455Integral membrane protein36.972YSYIC\*EK125.75bleBleomycin resistance protein14.922SIGFYC\*DK117.25SAOUHSC_01732Uncharacterized protein12.768KEGQGC\*ISLK92.247typAGTP-binding protein TypA37.865EIDGVMC\*EPFER191.89secAProtein translocase subunit SecA11.664NDDC\*.PC\*.GSGK70.68vraXProtein VraX6.5003C\*DDSFSDTEIFK128.06AYM28_07645YqiW-like protein16.014DAFDENC\*K129AYM28_05325UPF0738 protein AYM22_0532513.529IKDDILYC\*YTEDSIK108.28dltA[d]{.smallcaps}-alanine--poly(phosphoribitol) ligase subunit 154.67AGC\*GYVPVDTSIPEDR167.93SAOUHSC_02613Uncharacterized protein25.225AVC\*GFSK90.601SAOUHSC_01744Uncharacterized protein85.61VLNDQC\*PTSVK153.41AYM28_02495GIY-YIG catalytic domain protein9.1542C\*SDGSLYTGYAK114.31tagF_3CDP-glycerol--poly(glycerophosphate) glycerophosphotransferase66.074IDGNQFVC\*R111.5mqo1Probable malate : quinone oxidoreductase 154.785C\*TNQEVIDR135.04mqo1Probable malate : quinone oxidoreductase 154.785DGTVDC\*SK147.3N/APutative uncharacterized protein7.9711GEC\*DDKWEGLYSK104.76gnd6-Phosphogluconate dehydrogenase51.802DGASC\*VTYIGPNGAGHYVK98.76gnd6-Phosphogluconate dehydrogenase51.802IC\*SYAQGFAQMR155.33alr1Alanine racemase 142.823VC\*MDQTIVK114.72SAOUHSC_00696Uncharacterized protein34.777C\*GIILPSK110.41ychFRibosome-binding ATPase YchF13.516EVDAIC\*QVVR196.02tsfElongation factor Ts32.511TGAGMMDC\*K78.324xptXanthine phosphoribosyltransferase20.884LEEAGLTVSSLC\*K79.332mqo2Probable malate : quinone oxidoreductase 255.998EGC\*MNHLR122.94gmkGuanylate kinase24.037IQC\*IVEAEHLK100.11HMPREF0776_1272Mu transposase domain protein32.351NDTNWPVC\*GIPEK69.314MW1126Ribosome biogenesis GTPase A33.403IGNYC\*FDIFK65.809fabGβ-Ketoacyl-ACP reductase24.616GVFNC\*IQK121.73SAKOR_02572Transcriptional regulator, TetR family protein22.356ALLQC\*IEAGNNK89.484SAKOR_02572Transcriptional regulator, TetR family protein22.356SDLC\*YYVIQR129.82nthEndonuclease III25.668LC\*SVIPR78.264SA0511Uncharacterized epimerase/dehydratase36.052QGIANSWPDSIDTSC\*SR155.06SA0511Uncharacterized epimerase/dehydratase36.052VAGELLC\*QYYFK119tagF_2Putative teichoic acid biosynthesis protein45.954IC\*QTLFK66.056mnmGtRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG69.507YC\*PSIEDK131.09rpoADNA-directed RNA polymerase subunit alpha35.011SYNC\*LKR61.593tagBTeichoic acid biosynthesis protein B18.212C\*LPGYTLINK116.74SAOUHSC_01812Uncharacterized protein35.096C\*IEDNDTIIIHR141.34SAV1710Putative universal stress protein SAV171018.38HAPC\*DVLVVR131.83srtALPXTG-specific sortase A23.541QLTLITC\*DDYNEK152.32ST398NM01_1322Uncharacterized protein28.118SELEELC\*K118.23recGATP-dependent DNA helicase RecG78.343C\*IFFNQPYLK125.72SAKOR_00906Oligopeptide transport ATP-binding protein oppF16.074GETLGLVGESGC\*GK102.03murDMURD29.82NQTEEDYLIC\*NYHQR92.151SA0315Uncharacterized protein20.923C\*DAPMEVNK73.435HMPREF0776_06553-Demethylubiquinone-9 3-methyltransferase domain protein16.768VLC\*SDSFGR132.03SAOUHSC_02324Uncharacterized protein24.634QFFTEWNC\*HD141.58rncRibonuclease III27.922ATIVC\*EPSLVIFANK95.273topADNA topoisomerase I79.07C\*NDGDVVER92.151topADNA topoisomerase I79.07C\*NQYLVENK126.12rpmJ50S ribosomal protein L364.3VMVIC\*ENPK183.99SAZ172_2022Uncharacterized protein24.952TVIIDC\*VTK109.44N/AUncharacterized protein13.573GIDLNMGC\*PVANVAK167.93polC_2DNA polymerase III PolC-type4.1918TSIC\*SVGMVK67.952ackAAcetate kinase44.056IISC\*HIGNGASIAAIDGGK50.404SAOUHSC_02264Accessory gene regulator protein C13.754C\*ADDIPR101.46rnpARibonuclease P protein component11.093QFVVYTC\*NNK166.48rpmG50S ribosomal protein L335.87VNVTLAC\*TEC\*GDR134.08rpmG50S ribosomal protein L335.87VNVTLAC\*TEC\*GDR100.01N/AmRNA interferase PemK20.91FLC\*DSLK100.25graRResponse regulator protein GraR26.066YDGFYWC\*R123.79SAKOR_02101Uncharacterized protein42.899VVVLGC\*PAEEGGENGSAK95.755SAKOR_02241Molybdopterin biosynthesis MoeB protein37.894YATLC\*GR87.806cshBDEAD-box ATP-dependent RNA helicase CshB51.064C\*NAQPQLIIGTPTR86.016SACOL0939NifU domain protein7.9651DGGDC\*SLIDVEDGIVK163.45SAKOR_00091Ornithine cyclodeaminase family protein37.776VVVDDWSQC\*NR91.592SA2277Uncharacterized protein50.847TILC\*ALDVR107.34glnAGlutamine synthetase50.854GFTAVC\*NPLVNSYK229.96glnAGlutamine synthetase50.854LIC\*DVYK111.61glnAGlutamine synthetase50.854LVPGYEAPC\*YIAWSGK134.32glnAGlutamine synthetase50.854YADAVTAC\*DNIQTFK154.34whiAPutative sporulation transcription regulator WhiA35.868LVNC\*ETANLNK154.72whiAPutative sporulation transcription regulator WhiA35.868NNIYIC\*R157.91SAKOR_00683Transcriptional regulator, MarR family protein17.089EQLC\*FSLYNAQR207.66menB1,4-Dihydroxy-2-naphthoyl-CoA synthase30.411EIWYLC\*R154.12menB1,4-Dihydroxy-2-naphthoyl-CoA synthase30.411VEDETVQWC\*K185.57perRPeroxide-responsive repressor PerR17.183MEIYGVC\*K120.45SAOUHSC_00462Uncharacterized protein29.281GLSYEEVC\*EQTTK170tpxProbable thiol peroxidase18.005LISVVPSIDTGVC\*DQQTR81.656SAOUHSC_00960Uncharacterized protein57.927VTMTDYC\*YR87.216ybhF_3ABC transporter ATP-binding protein32.952LEDIELIC\*DR121.42BN1321_100031MutT/NUDIX family protein15.067C\*VCLVEETADK193.28SAKOR_00705Uncharacterized protein14.205YDEVTIYC\*K153.74SAOUHSC_01677Uncharacterized protein25.002TAQTVTDLRPAGIIFC\*ENER111.77SAKOR_00374Phosphoglycerate mutase family protein22.777SADDLC\*DYFK121.56sufBFe--S cluster assembly protein SufB52.531YPNC\*VLLGEGAK121.45ccpACatabolite control protein A12.161NGLQLGDTLNC\*SGAESYK140.07SAV0485Signal peptidase II-like protein23.935DAENALILC\*K85.672SAV0485Signal peptidase II-like protein23.935LVNC\*EYTLDK97.223sucDSuccinate-CoA ligase \[ADP-forming\] subunit alpha31.542LVGPNC\*PGVITADEC\*K249.56sucDSuccinate-CoA ligase \[ADP-forming\] subunit alpha31.542LVGPNC\*PGVITADEC\*K179.85sucDSuccinate-CoA ligase \[ADP-forming\] subunit alpha31.542TLNSC\*GVK91.469SAKOR_01205Transcriptional regulator, GntR family protein26.976EQSNHNIC\*YADTEIEAVNYEPR97.621SAKOR_01205Transcriptional regulator, GntR family protein26.976TADGEPVVYC\*LDK129.88SAOUHSC_02755Uncharacterized protein39.192YGC\*ALAIEVLK79.283ugtPProcessive diacylglycerol β-glucosyltransferase44.547SANAQVVMIC\*GK213.99ugtPProcessive diacylglycerol β-glucosyltransferase44.547YATQTIC\*R122.18MW0660MW0660 protein28.342TGC\*SASTIR104.07MW0924Uncharacterized protein18.511SC\*VDATYR89.171MW0924Uncharacterized protein18.511VAGC\*IISYSGENELK145.17MW0924Uncharacterized protein18.511WSLNC\*DINNEAALK126.04SAOUHSC_01973Uncharacterized protein35.778EAEILC\*YIDNIDAR77.505SAOUHSC_01973Uncharacterized protein35.778SIC\*DIYPLLNK112.44uppUracil phosphoribosyltransferase23.05FMC\*LIAAPEGVEK131.96SAOUHSC_02727Uncharacterized protein22.28C\*IYVQPHSYTIENQQQNK119.37MW0535MW0535 protein29.857AGEVYEASNAQYFVVDPVMVC\*K55.621HMPREF0776_0347CHAP domain protein12.753NLYTSGQC\*TYYVFDR78.615SAOUHSC_02574Uncharacterized protein40.742SCLNDC\*YDK139.74SAV2378Uncharacterized protein13C\*ANEEER63.624tagH_1Teichoic acids export ATP-binding protein TagH29.762MLC\*MGFK101.28CH52_060052-Dehydropantoate 2-reductase32.358QLLLDGC\*R82.279glySGlycine--tRNA ligase53.62IIDDEGIVC\*PVSK195.45glySGlycine--tRNA ligase53.62YIPYC\*IEPSLGADR107.98tpiATriosephosphate isomerase (TIM) (TPI)27.261HGMTPIIC\*VGETDEER135.95tpiATriosephosphate isomerase (TIM) (TPI)27.261SSTSEDANEMC\*AFVR142.93SAOUHSC_01716Uncharacterized protein47.655C\*TLSNHMTAR60.901SAOUHSC_01716Uncharacterized protein47.655TGATGIIVADPLIIETC\*K92.8vraS_1Histidine kinase (nitrate/nitrite sensor protein) (EC 2.7.3.-) (two-component sensor protein)41.88ALQEC\*INNVK101.61vicRDNA-binding response regulator (PhoP family transcriptional regulator)27.192DGMEVC\*R117.81SAOUHSC_02218Conserved hypothetical phage protein11.1EISNGHC\*NYWK144.51SAOUHSC_01696Uncharacterized protein22.463TIDC\*LNYYNYSDER154.72hsdS_2Restriction endonuclease subunit S23.781IPC\*LTEQDK102.87sufAChaperone involved in Fe--S cluster assembly12.485VAGNPENC\*106.16SAKOR_00641Ferrichrome transport ATP-binding protein fhuC29.496TGKPLLVTYDLC\*R90.755SAKOR_00641Ferrichrome transport ATP-binding protein fhuC29.496VTSIIGPNGC\*GK164.66HMPREF0769_12132ROK family protein35.077IILAADVGGTTC\*K103.13nadKNAD kinase30.769GDGLC\*VSTPSGSTAYNK102.24mraZTranscriptional regulator MraZ17.237EC\*TVIGVSNR109.16yutDUncharacterized protein conserved in bacteria15.401EC\*FNEEQFIAR15.401149.35SAZ172_0295Uncharacterized protein15.751C\*FEEEDFER164.48SAZ172_0295Uncharacterized protein15.751YIDC\*LEVGPTLSTK170gatAGlutamyl-tRNA(Gln) amidotransferase subunit A52.82DNIITNGLETTC\*ASK128.66MW0675MW0675 protein22.322YHSLIADGATFPNC\*LK80.905rpsR30S ribosomal protein S189.3098VC\*YFTANGITHIDYK100.69fusAElongation factor G64.009DTGTGDTLC\*GEK188fusAElongation factor G64.009KC\*DPVILEPMMK134.61fusAElongation factor G64.009KEFNVEC\*NVGAPMVSYR171.39fusAElongation factor G64.009QATTNVEFYPVLC\*GTAFK81.594rocD2Ornithine aminotransferase 243.417EEGLLC\*K133.86hutUUrocanate hydratase60.632GLSIEC\*K80.231narHNarH protein59.446RDEDGIVLVDQDAC\*R95.988SAOUHSC_00882Uncharacterized protein15.517LTIIDPHETFC\*QR93.839SAOUHSC_02811Uncharacterized protein27.165EC\*ATEITEVEDK115.68NWMN_2186Acyl-CoA dehydrogenase-related protein34.413METLLLC\*AR163.9fabF3-Oxoacyl-\[acyl-carrier protein\] synthase 242.433ALSTNDDIETAC\*R94.61fabF3-Oxoacyl-\[acyl-carrier protein\] synthase 242.433GPNGATVTAC\*ATGTNSIGEAFK70.501N/APutative uncharacterized protein24.022VDMIAC\*EDTR92.295ppaCProbable manganese-dependent inorganic pyrophosphatase34.068AEPVGC\*TATILYK136.26ppaCProbable manganese-dependent inorganic pyrophosphatase34.068IANFETAGPLC\*YR229.02ppaCProbable manganese-dependent inorganic pyrophosphatase34.068SPTC\*TQQDVK163.33AYM28_13750Nicotianamine synthase31.096SLQYITAQC\*VK120.21HMPREF0769_12162Transketolase, pyridine binding domain protein36.033SNNDWQC\*PLTIR110.57nosNitric oxide synthase oxygenase41.71EC\*HYETQIINK55.899nosNitric oxide synthase oxygenase41.71YAGYDNC\*GDPAEKEVTR147.84SAKOR_00998Hydroxymethylpyrimidine transport ATP-binding protein53.302VLLLGPSGC\*GK54.898SAOUHSC_01872Uncharacterized protein46.176C\*SQFVYK68.657SAV2122Putative aldehyde dehydrogenase SAV212251.968VVNNTGQVC\*TAGTR225.69SAOUHSC_02064Phi ETA orf 25-like protein15.401DVNLTWIC\*K79.089HUNSC491_pPR9_p11ATP-binding protein p271 (ATP-binding protein, putative)7.4555YQYIGIC\*YGQPGVGK91.065AYM28_02415Acetyltransferase (GNAT) family protein19.908AQEYSTVVVDHC\*FDYFEK87.963accDAcetyl-coenzyme A carboxylase carboxyl transferase subunit β31.52IIDYC\*TENR143.42ldh2[l]{.smallcaps}-lactate dehydrogenase 2 ([l]{.smallcaps}-LDH 2)34.42AGEYEDC\*KDADLVVITAGAPQKPGETR129.82gltXGlutamate--tRNA ligase18.695C\*YMTEEELEAER204.18srpFAlpha-helical coiled-coil protein19.257TYVC\*EDMSK193.22mnmAtRNA-specific 2-thiouridylase MnmA42.15DSTGIC\*FIGEK84.173mnmAtRNA-specific 2-thiouridylase MnmA42.15TPNPDVMC\*NK145.52V070_01284Uncharacterized protein48.871LPYTLC\*YISR145.61tmkUncharacterized protein51.081AQLIEC\*LEK79.886trxA_1Thiol reductase thioredoxin11.454IDLNFYPQFC\*K83.204pdxTPyridoxal 5′-phosphate synthase subunit PdxT20.63VGQGVDILC\*K126.71mcsBProtein-arginine kinase38.61SLGILQNC\*R63.694ydaGGeneral stress protein 2615.886EDPELC\*VLR152.7HMPREF0769_12370SWIM zinc finger domain protein15.906GFNYYQSEC\*VINLK157.73HMPREF0769_10247Oxidoreductase, FAD-binding protein42.831AFLANKPEIYIC\*GGTK107.15tarI1Ribitol-5-phosphate cytidylyltransferase 126.656SILSDAC\*K122.69SACOL2177Zinc-type alcohol dehydrogenase-like protein32.773QETTEWC\*EK218.02SAOUHSC_02146Uncharacterized protein40.354ESGC\*TVFQGK93.345SAOUHSC_02146Uncharacterized protein40.354LILENC\*R125.68SACOL2396Uroporphyrinogen III methylase SirB, putative36.29INDC\*IVEAAR113.37glpKGlycerol kinase55.625ATLESLC\*YQTR158.91glpKGlycerol kinase55.625QTQSIC\*SELKQQGYEQTFR125.84HMPREF3211_00337Methyltransferase domain protein21.763ALDIGC\*GSGLLVEK55.031tarJRibulose-5-phosphate reductase 138.451IPEGLTFDHAFEC\*VGGR60.968MW2550MW2550 protein29.096LLIMC\*GK113.41gpmI2,3-Bisphosphoglycerate-independent phosphoglycerate mutase56.423AIEAVDEC\*LGEVVDK144.75SAR1875Putative membrane protein insertion efficiency factor8.9865FYPTC\*SEYTR109.95serSSerine--tRNA ligase48.639EISSC\*.SNC\*.TDFQAR122.29serSSerine--tRNA ligase48.639FTGQSAC\*FR123.26serSSerine--tRNA ligase48.639MTGILC\*R123.21serSSerine--tRNA ligase48.639VILC\*TGDIGFSASK124.45MW2545MW2545 protein25.27GC\*TLILDEAK83.204femBAminoacyltransferase FemB49.675YLQQHQC\*LYVK83.53mfdTranscription-repair-coupling factor134.3LLC\*GDVGYGK84.605N/AKanamycin nucleotidyl transferase protein27IC\*YTTSASVLTEAVK119.62sdhASdhA protein65.502EIFDVC\*INQK265.75sdhASdhA protein65.502GLFAAGEC\*DFSQHGGNR110.77HMPREF0769_12639PHP domain protein8.9913ASLQVAC\*ENGK121.95SAZ172_1861Ribosomal large subunit pseudouridine synthase D-like protein31.387C\*VSPTGQR88.056NWMN_0748Uncharacterized protein28.19GIVTMC\*APMGGK138.55SAZ172_0851Pathogenicity island protein15.839IIC\*DFSTEREEK134.38SAKOR_01965RecT protein16.895NQC\*YFIPYGNK86.772gtf1Glycosyltransferase Gtf158.273SSFVTC\*YLQNEQK187.56fbpFructose-1,6-bisphosphatase class 376.213VC\*LANLLR91.087glmUBifunctional protein GlmU \[includes: UDP-*N*-acetylglucosamine pyrophosphorylase\]48.532EGTTIVVC\*GDTPLITK109.28glmUBifunctional protein GlmU \[includes: UDP-*N*-acetylglucosamine pyrophosphorylase\]48.532TNIGC\*GTITVNYDGENK155.26SAOUHSC_02464Uncharacterized protein32.803NIEAC\*TSLK62.162trxA_2Thiol reductase thioredoxin12.141FEAGWCPDC\*R119.87aroCChorismate synthase43.059VAVGALC\*K123.35MW0527MW0527 protein23.895AC\*GLTEPSSK168.85MW0527MW0527 protein23.895C\*GEVATQSAFK97.273lolD_1ABC transporter ATP-binding protein24.698AC\*IIVTHDER73.435pckAPhosphoenolpyruvate carboxykinase59.377NGVFNIEGGC\*YAK207.21glmSGlutamine--fructose-6-phosphate aminotransferase65.835C\*GIVGYIGYDNAK159.41ST398NM01_0974Uncharacterized protein81.447GELHC\*IGATTLNEYR166.21SAV0406Uncharacterized protein29.041GWNTLC\*TYLK147.39SAOUHSC_02980Uncharacterized protein20.729SC\*DIESVESWK130.19lysA_1Diaminopimelate decarboxylase9.757AFTC\*IQMVK106.26HMPREF0776_0362HTH domain protein26.531QC\*LSLPQTR63.966SAKOR_02509Transcriptional regulator, MarR family protein16.544VYMAC\*LTEK137.01SAOUHSC_00118Capsular polysaccharide biosynthesis protein Cap5E, putative38.591SEQTLIC\*GTR184.51SAOUHSC_00118Capsular polysaccharide biosynthesis protein Cap5E, putative38.591VIC\*LSTDK157.66SAOUHSC_02364Uncharacterized protein12.686MEVC\*PYLEETFK158.89SAOUHSC_02584Uncharacterized protein30.385AC\*HETVLK114.97SAOUHSC_02584Uncharacterized protein30.385GEGAFC\*NGIK114.72SAOUHSC_02584Uncharacterized protein30.385LIC\*SWLK118.33mapMethionine aminopeptidase27.358EIGYIC\*AK128.86QU38_16080Acyl-CoA ligase59.748LGVAIIPC\*SEMLR111.07AYM28_108056-Phosphogluconolactonase38.546AGTGC\*YVSISEDKR105.63AYM28_108056-Phosphogluconolactonase38.546EGEQC\*GVASLK153AYM28_108056-Phosphogluconolactonase38.546ITLC\*DNTR151.13SAOUHSC_02891Uncharacterized protein21.555SCELNSEAFC\*NK123.72SA2075Sulfur carrier protein FdhD19.75LYGFC\*IQR106.68pthPeptidyl-tRNA hydrolase21.703C\*IVGLGNIGK84.31dnaKChaperone protein DnaK66.361IIGIDLGTTNSC\*VTVLEGDEPK89.507SAOUHSC_01064Pyruvate carboxylase18.812C\*AEEGIK18.81277.73sarRHTH-type transcriptional regulator SarR13.669C\*SEFKPYYLTK98.421lepAElongation factor 428.674C\*YGGDISR128.35asnSAsparagine--tRNA ligase49.157SVLENC\*KLELK125.97pfkAATP-dependent 6-phosphofructokinase34.839C\*PEFKEQEVR108.97SAKOR_01872Uncharacterized protein12.527FILSTSDDSDYIC\*K91.589lipA_2Lipoyl synthase34.885HC\*QAGPLVR83.08lipA_2Lipoyl synthase34.885NLNTVC\*EEAK222.56V070_00687Uncharacterized protein27.971LINPDC\*K128.35SAOUHSC_00532Uncharacterized protein42.89NDAILSDELNHASIIDGC\*R87.411rnj2Ribonuclease J 2 (RNase J2)62.603LIVSC\*YASNFIR118.71MW1645MW1645 protein44.233C\*FEIEER74.165miaB_1MiaB family protein, possibly involved in tRNA or rRNA modification50.955STVAFHTLGC\*K79.614ungUracil-DNA glycosylase (UDG)24.967ELADDIGC\*VR138.24glpDAerobic glycerol-3-phosphate dehydrogenase62.387KDYGLTFSPC\*NTK250.46SAV0941NADH dehydrogenase-like protein44.104IATPIVAC\*NEK236.05SAV0941NADH dehydrogenase-like protein44.104IPELC\*SK154.01MW2452MW2452 protein24.558LDC\*KDEFIK89.189SA1530Uncharacterized peptidase39.606QVLFC\*PK132.76pheT_2Phenylalanine--tRNA ligase β subunit12.153GVASSGMIC\*SMK86.772SAKOR_02579Putative cytosolic protein11.547YMFDYSAC\*K90.614AYM28_07495DNA-binding protein12.72HYQQLINQC\*K121.29gcvPBProbable glycine dehydrogenase (decarboxylating) subunit 222.485NFGVDNGFYPLGSC\*TMK102.15NWMN_0123Uncharacterized protein151.91SLLEC\*VK99.013adhAlcohol dehydrogenase (ADH)36.061LDPAAASSITC\*AGVTTYK210.33dnaJDnaJ29.458TEQVC\*PK88.495guaBInosine-5′-monophosphate dehydrogenase52.85VGIGPGSIC\*TTR119.46N/AUPF0413 protein25.089C\*QAQSTSNFDNIALAYK125.39SAKOR_00478VEG protein9.9982NSIDC\*HVGNR76.868mutSMutS protein48.889SEYQDC\*LLFFR79.885mutSMutS protein48.889VAIC\*EQMEDPK125.36yibNPutative sulfur transferase14.803KDQPVYLC\*DANGIASYR78.191ileSIsoleucine--tRNA ligase104.74C\*KEFALEQIELQK116.61SAOUHSC_01907Uncharacterized protein31.471VENDENC\*MESVK159.04nagBGlucosamine-6-phosphate deaminase28.467QASFYVAC\*ELYK106.82SAKOR_02240Molybdenum cofactor biosynthesis protein B18.5DFDTDKGGQC\*VR93.716nirBNitrite reductase \[NAD(P)H\], large subunit46.979SC\*VESGVK65.627tetMTetracycline resistance protein TetM70.346GPSELC\*GNVFK69.261thyATranslation initiation factor IF-336.825LSC\*QLYQR55.721SAOUHSC_01781Uncharacterized protein36.431FANC\*TQELTIEK110.6miaBUncharacterized protein58.916AWVNIMYGC\*DK135.91miaBRNA methyltransferase TrmA family protein58.916YEGQTVTVLC\*EGSSK188.32pgcAFructose-1,6-bisphosphate aldolase62.376C\*PNFDDVAQK151.3SAKOR_02003Ribosomal protein-serine acetyltransferase27.906C\*HNSFVVNR98.407SAKOR_02003Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO27.906IFIC\*EDDPK142.19SAKOR_02003Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO27.906IIDC\*LETAHTR170.95SAV1153Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO19.255GNC\*DFYPEFENEAVAK76.341ftsHPeptide methionine sulfoxide reductase MsrB77.812IC\*GLLGGR124.08HMPREF0769_10485Putative peptide methionine18.28LDSPYDGYAEC\*VK115.26sepFCell division protein SepF20.686MC\*LFEPR120.15SAOUHSC_02898Uncharacterized protein24.931VNSLAYC\*SSK128.85sucCSuccinate-CoA ligase \[ADP-forming\] subunit β42.056C\*DVIAEGIVEAVK189.04sucCSuccinate-CoA ligase \[ADP-forming\] subunit β42.056RLYIEEGC\*AIQK231.07SA2102Putative formate dehydrogenase111.29FAEEC\*AK160.82SA2102Putative formate dehydrogenase111.29GHNNVQGC\*SDMGSMPDK88.108SA2102Putative formate dehydrogenase111.29QVIGTNNVDNC\*SR175.19SA2102Putative formate dehydrogenase111.29YC\*QAPATK117.25SAKOR_00737Ferric anguibactin transport ATP-binding protein28.62STLLSAIC\*R103.43SAOUHSC_01323Uncharacterized protein29.821QDFDEIVDYC\*R127.05SAOUHSC_02248Uncharacterized protein17.196IIGLSGMC\*K68.132taqDGlycerol 3-phosphate cytidyltransferase15.789C\*EVIYLK51.528AYM28_05950Uncharacterized protein15.185FQMINDC\*AEK64.52queA*S*-adenosylmethionine:tRNA ribosyltransferase-isomerase38.97IIAEC\*IK138.08SAOUHSC_000863-Ketoacyl-acyl-carrier protein reductase, putative27.215IINATSQAGVEGNPGLSLYC\*STK70.572glcTProtein GlcT32.822NHYPIC\*YNTAYK118.52AYM28_01135AraC family transcriptional regulator29.599VVIC\*DDER129.82AYM28_01135AraC family transcriptional regulator29.599YLQMSPSDYC\*K115.09AYM28_13045Putative 3-methyladenine DNA glycosylase22.771AIDGATLNDC\*R116.58tyrCArogenate dehydrogenase40.395C\*LNYSEAIK68.676SAOUHSC_02899Uncharacterized protein38.194AIELC\*QK143.37SAR2150Protein SprT-like17.186ANYEYYC\*TK166.62SAR2150Protein SprT-like17.186FC\*NSIESYQQR97.797SA0314Uncharacterized protein20.027LDC\*AEIIR73.841SA1974Probable uridylyltransferase44.865LVNVDC\*K82.417hemHFerrochelatase35.056VVC\*DDIGANYYRPK112.24hptHypoxanthine-guanine phosphoribosyltransferase20.154EVLLTEEDIQNIC\*K103.39SAOUHSC_00548Uncharacterized protein58.418GFLSC\*SR94.309SAOUHSC_00531Uncharacterized protein43.657VRPGAFFLTGC\*GNESK74.296tnpPutative transposase8.5839GIEC\*IYALYK90.614cap5GCapsular polysaccharide biosynthesis protein Cap5G42.851C\*FDQNVPEEINR186.96SAOUHSC_00973Uncharacterized protein27.727VC\*YQVFYDEK138.02ykaAPhosphate transport regulator22.598EFETNC\*DGILR133.48hprKHPr kinase/phosphorylase34.481LC\*RPETPAIIVTR98.508murA1UDP-*N*-acetylglucosamine 1-carboxyvinyltransferase 144.995LGHAIVALPGGC\*AIGSR67.846rocA1-Pyrroline-5-carboxylate dehydrogenase56.867GC\*TSAVVGYHPFGGFK103.67HMPREF0769_10271Oxidoreductase, NAD-binding domain protein39.204AAC\*AAEAYGTDNAK78.917ahpCAlkyl hydroperoxide reductase20.976KNPGEVC\*PAKWEEGAK127.78mvaSHMG-CoA synthase43.217EAC\*YAATPAIQLAK226.7SAKOR_00677Cytokinin riboside 5′-monophosphate phosphoribohydrolase20.889ALAPLC\*DTK137.4SAKOR_00677Cytokinin riboside 5′-monophosphate phosphoribohydrolase20.889IAVYC\*GASK122.33pcrAATP-dependent DNA helicase PcrA84.073IC\*YVAITR109.83N/APutative uncharacterized protein15.429EQGSDIDAAC\*GQLR137.52rimPRibosome maturation factor RimP17.627EGGVDLNDC\*TLASEK197.6asp1Accessory Sec system protein Asp153.78EC\*ITSVNEEYQAK188SAUSA300_2158Uncharacterized protein14.457DDNILC\*EEFSYK79.393SAKOR_00594Trp repressor-binding protein20.243VILVGGDC\*PK186.76SAOUHSC_02447Uncharacterized protein36.266VPVC\*GAISSYNHPEADIGPR126.62SAOUHSC_00497Uncharacterized protein53.954NGLTLQEC\*LDR114.64SAOUHSC_00497Uncharacterized protein53.954SIFPSC\*R68.557pykPyruvate kinase63.102C\*DILNSGELK126.71pykPyruvate kinase63.102IVC\*TIGPASESEEMIEK96.561pykPyruvate kinase63.102QC\*SIVWGVQPVVK172.11rpoBDNA-directed RNA polymerase subunit β133.22FMDDEVVC\*R92.247yigZABC transporter23.868EAVPC\*IVTLNYDQTGK120.21yigZABC transporter23.868LDVHNAC\*VVVTR98.182N/AUncharacterized protein32.909NESLC\*ELKK140.63SAOUHSC_01365Uncharacterized protein37.855SHLVNLC\*K99.788SA2162Ferredoxin--NADP reductase38.164C\*NTLLSETSSK186.08SA2162Ferredoxin--NADP reductase38.164LDMHDDC\*R64.224infCTranslation initiation factor IF-320.244YADEC\*KDIATVEQKPK88.311SAOUHSC_02827Uncharacterized protein10.548IIASC\*SFAK135.1SAOUHSC_02579Uncharacterized protein41.89VLYQGYTC\*FR109.99NWMN_1835RNA methyltransferase TrmA family protein51.682IVYISC\*NPATQQR216.34fbaFructose-bisphosphate aldolase30.836EC\*QELVEK97.472SAKOR_00338Ribosomal protein-serine acetyltransferase20.294YC\*FEELDLNR77.644trmFOMethylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase48.371FAELVC\*SNSLR144.4trmFOMethylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase48.371YDKGEAAYLNC\*PMTEDEFNR90.259trmFOMethylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase48.371YFEGC\*MPFEVMAER85.937msrBPeptide methionine sulfoxide reductase MsrB16.277FHSEC\*GWPSFSK125.33msrBPeptide methionine sulfoxide reductase MsrB16.277YC\*INSAAIQFIPYEK144.3ytqAFe--S oxidoreductase36.053VALDGGFDC\*PNR116.87yjlDNADH dehydrogenase39.399IYNC\*DEPK160.72SAZ172_2586Mutator mutT protein11.465C\*DLIVGDK63.073AYM28_03635Protein of uncharacterized function14.312IMYC\*FNK132.08SAKOR_01397ATP-dependent helicase, DinG family protein104.19C\*LVLFTSYK112.13SAOUHSC_02393Uncharacterized protein25.34C\*LANNDVQIMNSIK78.674panDAspartate 1-decarboxylase14.05IC\*LNGAASR112.64purAAdenylosuccinate synthetase47.551IC\*TAYELDGK104.59fhsFormate--tetrahydrofolate ligase59.871QFKENGWDNYPVC\*MAK200SAZ172_20845-Amino-6-(5-phosphoribosylamino)uracil reductase15.666AFQILHEQYGC\*K51.727gatB_2Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B53.656C\*DANISLRPYGQEK76.574SAZ172_2659[d]{.smallcaps}-specific [d]{.smallcaps}-2-hydroxyacid dehydrogenase-like protein37.264DAVFVNC\*AR73.435folPDihydropteroate synthase29.532SEVAEAC\*LK115.33AYM28_03210Deoxyguanosinetriphosphate triphosphohydrolase50.595GGEVLLNNC\*LK164.22

Furthermore, the prevalence of hydrophobic and positively charged amino acids flanking modified cysteines was observed when linear amino acid sequences and available 3D structures of CoAlated proteins were examined using computational methods (manuscript in preparation).

To sense and overcome the oxidative stress, *S. aureus* employs oxidation-sensing transcriptional regulators, such as MgrA, SarZ and SarA, and the quorum-sensing Agr system which controls global gene expression via the redox-active Cys residues \[[@BCJ-475-1909C44],[@BCJ-475-1909C45]\]. It was interesting to find redox-sensing transcriptional regulators detected among CoAlated proteins. In total, 16 CoA-modified peptides from 12 transcriptional regulators, including SarR, CtsR, AgrA, PerR and SarS, were found in diamide-treated *S. aureus*. Induction of the CtsR and PerR regulons in NaOCl-treated *B. subtilis* was found to be indicative of the disulfide stress response \[[@BCJ-475-1909C46]\]. PerR exists in Gram-positive bacteria as a functional homolog of OxyR and functions as a sensor of oxidative stress. PerR possesses four cysteine residues, which are involved in Zn coordination, dimerization and DNA binding. One of these cysteines, Cys142, was found to be CoAlated in diamide-treated *S. aureus*. The effect of PerR CoAlation on its DNA-binding and transcriptional activities in response to oxidative and metabolic stress remains to be investigated.

The quorum-sensing transcriptional regulator AgrA was CoAlated on Cys6 and Cys199 in diamide-treated cells. The oxidation-sensing role of Cys199 in AgrA was revealed in mutational, biochemical and mass spectrometric analyses \[[@BCJ-475-1909C47]\]. The formation of the intracellular disulfide bond between Cys199 and Cys228 was shown to cause the dissociation of AgrA from DNA. It would be interesting to examine the pattern of AgrA CoAlation in *S. aureus* exposed to different stresses, including nitrogen and carbohydrate deprivation, exposure to heat, UV and oxidizing chemicals. Furthermore, *in vitro* CoAlation of recombinant AgrA at Cys199 has the potential to modify its DNA-binding and transcriptional activities.

Other targets of protein CoAlation are antioxidant proteins, including thioredoxin (Trx), alkyl hydroperoxide reductase C (AhpC), thiol peroxidase (Tpx), malate : quinone oxidoreductases 1 and 2 (Mqo1/2), FAD-binding protein oxidoreductase (HMPREF0769_10247) and Fe--S oxidoreductase (YtqA). In Tpx, diamide-induced CoAlation occurs on the active site Cys60 and the relevance of this modification is yet to be fully understood. Interestingly, Tpx peroxidase was shown to be S-mycothiolated at Cys60 in *Corynebacterium glutamicum* and its activity inhibited by *in vitro* S-mycothiolation \[[@BCJ-475-1909C42]\].

In addition, many ribosomal proteins were found to be CoAlated, including L12, S12, L14, S18, L32, L33 and L36. Recently, ribosomal proteins L33 (RpmG3) and L36 (RpmJ) were found to be S-bacillithiolated within the CXXC motifs at conserved Zn-binding sites in *S. aureus* treated with NaOCl \[[@BCJ-475-1909C25]\]. Oxidation of cysteines in ribosomal proteins, especially in the CXXC motif, was reported in various studies, and it has been suggested that disulfide stress could lead to a stalling of the ribosomes and thus, to the release of the alarmone ppGpp \[[@BCJ-475-1909C48],[@BCJ-475-1909C49]\]. Furthermore, glutathionylation of ribosomal protein S12 was found in oxidatively stressed human T lymphocytes, but the importance of this modification has not been investigated \[[@BCJ-475-1909C50]\]. The identification of many ribosomal proteins as targets for CoAlation may suggest the inhibitory effect of this modification on protein biosynthesis under oxidative stress.

The largest functional group of CoAlated proteins includes metabolic enzymes that function in diverse anabolic and catabolic pathways for carbohydrates, amino acids, nucleotides, fatty acids, coenzymes and antioxidants ([Figure 4B](#BCJ-475-1909F4){ref-type="fig"} and [Table 1](#BCJ-475-1909TB1){ref-type="table"}). Among CoAlated proteins, we found key players of the citric acid cycle, glycolysis, gluconeogenesis, glycerol catabolism and the glyoxylate shunt. These included glyceraldehyde-3-phosphate dehydrogenase 2 (GapA2), pyruvate kinase (Pyk), ATP-dependent 6-phosphofructokinase (PfkA), acetate kinase (AckA), alcohol dehydrogenase (Adh), aldehyde dehydrogenase 1 (AldA1), triose phosphate isomerase (TpiA), manganese-dependent inorganic pyrophosphatase (PpaC), fructose-1,6-bisphosphate aldolase (Fbp), glycerol kinase (GlpK), inosine-5′-monophosphate dehydrogenase (GuaB), malate dehydrogenase (Mdh) and others. In the list of CoAlated metabolic enzymes, we found several enzymes, which are known to be modified by other LMW thiols, including glutathione, bacillithiol and mycothiol. For example, GAPDH, GuaB and AldA were shown to be S-bacillithiolated in *S. aureus* under NaOCl stress \[[@BCJ-475-1909C25]\]. Mycothiolation of GuaB and Fbp in *C. glutamicum* treated with NaOCl was previously reported \[[@BCJ-475-1909C34]\]. In Gram-negative bacteria, GAPDH, TpiA and PpaC were shown to be glutathionylated in oxidative stress response \[[@BCJ-475-1909C51],[@BCJ-475-1909C52]\]. Extensive CoAlation of metabolic enzymes in response to oxidative stress may reflect the potential involvement of CoA in regulatory and/or feedback mechanisms which control metabolic pathways by balancing the redox state.

*In vivo* CoAlation of SaGAPDH in response to various oxidizing agents {#s3d}
----------------------------------------------------------------------

GAPDH homologs in eukaryotic and prokaryotic cells have been found in numerous studies as targets for oxidation and subjects for redox-controlled post-translational modifications, including S-glutathionylation, bacillithiolation and mycothiolation. These modifications were mapped to a strictly conserved catalytic site cysteine and shown to inhibit the activity of GAPDH, and to protect the catalytic cysteine from irreversible overoxidation. Two homologs of GAPDH have been identified in *S. aureus*, termed GAPDH1 and GapA2. In the present study, diamide-induced CoAlation was shown to modify the GapA2 isoform at a non-catalytic Cys202. Protein sequence analysis revealed that trypsin/Lys C digestion of SaGAPDH and GapA2 would produce very long peptides, containing catalytic active cysteines 151 and 153, respectively, making their analysis by LC--MS/MS less feasible. To date, detailed structure--function analysis has been carried out mainly for the SaGAPDH isoform. Therefore, we investigated SaGAPDH CoAlation *in vitro* and *in vivo*, and examined the effect of this modification on its activity. Initially, our efforts were focused on validating *in vivo* CoAlation of SaGAPDH in response to diamide and testing the effect of other oxidizing agents. To do so, *E. coli* transformed with the pQE3/SaGAPDH plasmid were grown at 37°C in LB medium to mid-log phase (OD~600~ = 0.7) and induced with 0.1 mM IPTG for 3 h at 30°C. Bacterial cultures were then treated for 30 min at 37°C with 2 mM diamide, 10 mM H~2~O~2~ and 100µM NaOCl. Ni-NTA Sepharose was used to capture His-SaGAPDH from lysed cells and the pulled-down proteins were analyzed by SDS--PAGE and immunoblotting with anti-CoA antibody. As shown in [Figure 5A](#BCJ-475-1909F5){ref-type="fig"} (right panel), the level of pulled-down His-SaGAPDH was nearly the same in all examined samples. No CoAlation of His-SaGAPDH was detected in control cells, while the treatment of cells with 2 mM diamide induced strong CoAlation of His-SaGAPDH. The strongest CoAlation of His-SaGAPDH was observed in response to NaOCl and a weak immunoreactive signal was detected in H~2~O~2~-treated cells. Figure 5.*In vitro* and *in vivo* CoAlation of SaGAPDH.(**A**) CoAlation of SaGAPDH overexpressed in *E. coli* is strongly induced by oxidizing agents. The expression of His-tagged SaGAPDH in *E. coli* transformed with the pQE3/SaGAPDH plasmid was induced with 0.1 mM IPTG for 3 h at 30°C. Bacterial cultures were then treated with 2 mM diamide, 10 mM H~2~O~2~ and 100 µM NaOCl for 30 min. Ni-NTA Sepharose was used to pull-down His-SaGAPDH and protein CoAlation analyzed by immunoblotting with anti-CoA antibody. (**B**) *In vitro* CoAlation of recombinant SaGAPDH. Recombinant preparations of His-SaGAPDH were incubated with 2 mM CoA dimer (CoASSCoA). NEM (25 mM) was added and samples were heated in loading buffer with or without DTT. CoAlation of enzymes was examined by anti-CoA immunoblot. (**C**) LC--MS/MS spectrum of a CoAlated peptide derived from *in vitro* CoAlated SaGAPDH. The spectrum shows a peptide from SaGAPDH (LDGSETVVSGASC\*TTNSLAPVAK), containing CoAlated catalytic cysteine 151.

Next, we investigated the effect of *in vitro* CoAlation on the activity of SaGAPDH. In the present study, recombinant His-SaGAPDH was purified by Ni-NTA Sepharose chromatography from *E. coli* transformed with the pQE3/His-SaGAPDH plasmid. To produce CoAlated SaGAPDH, an *in vitro* CoAlation assay was performed in the presence of recombinant SaGAPDH and CoASSCoA. Immunoblotting of reaction mixtures with the 1F10 antibody revealed a strong immunoreactive signal corresponding to the SaGAPDH sample incubated with CoA disulfide ([Figure 5B](#BCJ-475-1909F5){ref-type="fig"}). No immunoreactivity was detected in the sample separated under reducing conditions (100 mM DTT). The LC--MS/MS analysis of *in vitro* CoAlated SaGAPDH showed that catalytic Cys151 is CoAlated in the LDGSETVVSGASC\*TTNSLAPVAK peptide ([Figure 5C](#BCJ-475-1909F5){ref-type="fig"}).

*In vitro* CoAlation of SaGAPDH prevents irreversible inhibition of its enzymatic activity by H~2~O~2~ {#s3e}
------------------------------------------------------------------------------------------------------

GAPDH homologs in eukaryotic and prokaryotic cells have been shown to be readily inhibited by a variety of ROS and the inhibitory effect is mediated by direct oxidation of the catalytic active cysteine located in a highly conserved CTTNC motif. Studies from several laboratories revealed that SaGAPDH is very sensitive to irreversible oxidation to sulfonic acid when *S. aureus* is treated with 100 mM H~2~O~2~ \[[@BCJ-475-1909C25],[@BCJ-475-1909C53]\].

We initially examined a dose-dependent inhibition of recombinant SaGAPDH with H~2~O~2~. Purified His-SaGAPDH was incubated in the absence or presence of 1 μM, 10 μM, 100 μM, 1 mM or 10 mM H~2~O~2~ for 10 min before the activity was measured spectrophotometrically, as described in Experimental procedures. As shown in [Figure 6A](#BCJ-475-1909F6){ref-type="fig"}, exposure of SaGAPDH to 10 μM H~2~O~2~ results in a ∼50% decrease of its catalytic activity. The presence of 1 mM H~2~O~2~ in the reaction mixture resulted in 95% inhibition, while 10 mM H~2~O~2~ completely blocked SaGAPDH activity. These data indicate that SaGAPDH is efficiently inhibited by ROS-mediated direct oxidation of its catalytic active cysteine. Further analysis revealed that the inactivation of SaGAPDH activity by 10 mM H~2~O~2~ was only partially reversible, as only 40% of SaGAPDH activity could be recovered with 10 mM DTT ([Figure 6B](#BCJ-475-1909F6){ref-type="fig"}). The addition of DTT to the untreated sample of SaGAPDH increased its activity by ∼50%, indicating partial and reversible oxidation of recombinant preparations of His-SaGAPDH during the storage. Figure 6.Testing the effect of CoAlation on SaGAPDH activity *in vitro*.*In vitro* CoAlation prevents H~2~O~2~-induced overoxidation of recombinant SaGAPDH dose-dependent inhibition of SaGAPDH activity by H~2~O~2~ *in vitro*. (**B**) *In vitro* CoAlation inhibits SaGAPDH activity. (**C**) H~2~O~2~-induced inhibition of SaGAPDH activity is only partially reversed by DTT. (**D**) The inhibition of SaGAPDH activity by *in vitro* CoAlation is fully reversed by DTT.

Next, we investigated the effect of CoAlation on SaGAPDH catalytic activity. As shown in [Figure 6C](#BCJ-475-1909F6){ref-type="fig"}, *in vitro* CoAlation of SaGAPDH resulted in 90% inhibition of its activity. The inhibitory effect of CoAlation on SaGAPDH activity was completely reversed by the addition of 10 mM DTT to the reaction mixture. In line with these results, we have recently reported significant inhibition (∼80%) of mammalian GAPDH by *in vitro* CoAlation, which was fully reversed by DTT \[[@BCJ-475-1909C22]\]. These findings prompted us to examine whether CoAlation can protect SaGAPDH catalytic activity against irreversible overoxidation by H~2~O~2~. In the agreement with the above findings, SaGAPDH was fully inactivated with 10 mM H~2~O~2~ and the addition of 10 mM DTT recovered only 40% of the enzymatic activity ([Figure 6D](#BCJ-475-1909F6){ref-type="fig"}). We subsequently found that *in vitro* CoAlation of SaGAPDH before exposure to 10 mM H~2~O~2~ resulted in nearly 100% recovery of its activity with DTT. These results indicate that SaGAPDH CoAlation can prevent irreversible overoxidation of the catalytic Cys151 under the oxidative stress.

Analysis of GAPDH/CoA interaction by MD simulation {#s3f}
--------------------------------------------------

In the glycolysis pathway, GAPDH functions to convert glyceraldehyde 3-phosphate to the energy-rich intermediate 1,3-bisphosphoglycerate and uses inorganic phosphate to harness the energy into NADH \[[@BCJ-475-1909C54]\]. Biochemical, mutational and crystallographic studies of GAPDH from prokaryotic and eukaryotic cells have revealed that the active site cysteine is essential for the catalytic activity of the enzyme. GAPDH consists of four identical non-covalently connected subunits, which possess the NAD^+^-binding domain and the catalytic domain. Each subunit contains a strictly conserved catalytic cysteine, which is susceptible to various thiol modifications in cellular response to oxidative stress, including sulfenylation, glutathionylation, nitrosylation, bacillithiolation and mycothiolation \[[@BCJ-475-1909C55]\]. These modifications inhibit GAPDH activity and glucose metabolism, and divert a metabolic flux through the pentose phosphate cycle to increase NADPH production.

Recently, a crystal structure of overoxidized SaGAPDH revealed an apo form of the enzyme lacking NAD^+^ in the binding pocket \[[@BCJ-475-1909C25]\]. Taking this into account and the fact that SaGAPDH is CoAlated in response to H~2~O~2~ and NaOCl, we hypothesized that the ADP moiety of CoA may also be involved in mediating the interaction with SaGAPDH by occupying the vacant nucleotide-binding pocket. To investigate the binding mode between CoA and SaGAPDH, we performed MD simulations. In the present study, the structure of the CoA : GAPDH complex was modeled onto the GAPDH structure with NAD^+^ (PDBID: 3LVF). The adenine moieties of both cofactors were aligned to start from a structure with CoA bound in the NAD adenine-binding site. CoA remains firmly bound to the protein during a long 400 ns MD run in explicit solvent, suggesting that CoA can indeed bind to the NAD^+^ binding site. As (un)binding events can occur on a wide range of timescales, from μs to hours, they cannot be captured by the limited timescales accessible to standard MD simulations. For this reason, we employed metadynamics to enhance the sampling and accelerate the occurrence of these rare events. The free energy landscape reconstructed after a 400 ns metadynamics run is shown in [Figure 7A](#BCJ-475-1909F7){ref-type="fig"}. In this map, the most stable conformation (labeled MD-A) has CoA-folded onto itself and occupies the deep cavity in proximity of the nicotinamide-binding site. In this conformation, the CoA thiol group is quite close to catalytic Cys151 (at ∼7--8 Å, highlighted as a red sphere in the figure). A nearby secondary minimum (MD-B) is also present, structurally similar to A, but for which the CoA thiol group and Cys151 are within bond distance (SH--SH distance of 4 Å). This conformation is only 1.8 kcal/mol higher in energy, suggesting that interactions between the CoA thiol and Cys151 are not only possible, but might lead to covalent binding. An alternative metastable basin (MD-C) is also observed in the free energy map. In this conformation, CoA is bound to the NAD^+^ adenine-binding site, as in the starting X-ray structure. As in the case of MD-B, this minimum is very close in energy to lowest basin MD-A, being only 1.3 kcal/mol less stable. Interestingly, CoA can approach Cys151 also from this conformation, by assuming a bridge conformation that connects the adenine- and nicotinamide-binding sites (labeled MD-D in [Figure 7A](#BCJ-475-1909F7){ref-type="fig"}). Figure 7.The mode of interaction between SaGAPDH and CoA.(**A**) Free energy landscape of the CoA : GAPDH complex as a function of the distance between Cys151 (shown as a red ball in the exemplary structures) and the CoA SH tail (*x*-axis) and the PO^3^ group attached to the sugar moiety (*y*-axis). The contour lines are drawn every 2 kcal/mol. CoA and, for reference, NAD are shown in blue and magenta sticks, respectively. The computed free energy landscape reveals how CoA can assume different conformations, folded onto itself (labeled as A in the map) near the nicotinamide-binding site (as shown in the corresponding figure on the lower left corner), or binding the adenine-binding site (MD-B). The CoA tail can approach Cys151 from both these minima or by assuming the conformations found in basin MD-D (top left corner) when starting from the extended conformation observed in basin MD-C (top right corner). The latter basins are slightly higher energy when compared with the absolute minimum, but still accessible. (**B**) A proposed model of CoA binding to SaGAPDH, where CoA binds to the nicotinamide-binding site and its tail approaches Cys151 forming a covalent bond.

In the holoenzyme structure, the NAD^+^ occupies the nucleotide-binding pocket and prevents the formation of bonds with the ADP moiety of CoA. The absence of NAD^+^ in the apoenzyme structure allows this ADP moiety to occupy the nucleotide-binding pocket.

Taken together the above findings and published studies in the literature, we propose that the interaction between CoA and the oxidized form of GAPDH is facilitated by the ADP moiety of CoA which can occupy the vacant nucleotide-binding pocket, while permitting the pantetheine tail of CoA to form a covalent disulfide bond with Cys151.

Discussion {#s4}
==========

The presence of a highly reactive thiol group and the ADP moiety in the CoA structure offer diverse functions in biochemical processes. Using a thiol group, CoA reacts with carboxylic acids to form diverse thioesters, thus functioning in cellular metabolic processes as a master acyl group carrier. It also functions as a carbonyl-activating group in numerous anabolic and catabolic processes, including the citric acid cycle and fatty acid metabolism. In addition, CoA provides the 4-phosphopantetheine prosthetic group to proteins that play key roles in fatty acid, polyketide and non-ribosomal peptide biosynthesis. A novel unconventional function of CoA in redox regulation, involving oxidative S-thiolation of cellular proteins (termed protein CoAlation), has recently emerged as a new research field \[[@BCJ-475-1909C22]\]. In this original study, extensive protein CoAlation was observed in mammalian cells and tissues in response to oxidative and metabolic stress. Developed research tools and a mass spectrometry methodology allowed the identification of 587 CoAlated proteins under various experimental conditions in cell-based and animal models (\[[@BCJ-475-1909C22]\] and unpublished data). Bioinformatic pathway analysis of CoAlated proteins showed that they are involved in diverse cellular processes, including metabolism, protein synthesis and stress response. Furthermore, catalytic activities of several metabolic enzymes, including creatine kinase, isocitrate dehydrogenase 2, pyruvate dehydrogenase kinase 2 and GAPDH, were shown to be inhibited by *in vitro* CoAlation. Here, we demonstrate for the first time that protein CoAlation also occurs in prokaryotic cells and is associated with redox regulation. Evidence is provided that exponentially growing Gram-negative and Gram-positive bacteria exhibit a basal level of protein CoAlation, while exposure to oxidizing agents and glucose deprivation induce strong covalent protein modification by CoA in a DTT-sensitive manner.

The intracellular concentration of CoA and its derivatives in bacteria varies from 0.4 mM in *E. coli* to low millimolar level in *S. aureus* \[[@BCJ-475-1909C1],[@BCJ-475-1909C56],[@BCJ-475-1909C57]\]. The level of CoA and the ratio between CoA and its thioesters fluctuate depending on the growth conditions and are regulated by the availability of nutrients, intracellular metabolites and the exposure to stress. In exponentially growing *E. coli*, four CoA species (CoASH, acetyl CoA, succinyl CoA and malonyl CoA) compose the bulk of the CoA pool, where acetyl CoA is the dominant component (79.8%) and the level of CoASH is significantly lower (13.8%) \[[@BCJ-475-1909C57]\]. When glucose in the medium is depleted, CoASH becomes the major component (82%) of the CoA pool at the expense of the acetyl CoA derivatives. The same effect was also observed in cells treated with the oxidizing agent or cultured in the glucose-deprived medium \[[@BCJ-475-1909C57]\]. The production of metabolically active CoA thioesters has been associated with cell growth, while the increase in the level of CoASH under adverse growth conditions may allow bacteria to sense, respond and adapt to excessive ROS accumulation via thiol-mediated protein CoAlation.

The redox proteome analysis of *S. aureus* enabled us to identify 356 CoAlated proteins which belong to diverse functional classes. The main targets of CoAlation are proteins involved in cellular metabolism, translation and antioxidant response, and this pattern correlates with that in mammalian cells and tissues \[[@BCJ-475-1909C22]\]. In contrast with mammalian CoAlome, many redox-dependent transcription factors, whose DNA-binding activity is modulated in response to cysteine oxidation, have been identified in diamide-treated *S. aureus*. These include transcriptional regulators SarR, CtsR, AgrA, PerR and SarS, which control the expression of genes involved in oxidative stress response, antibiotic resistance, virulence or catabolism of aromatic compounds.

To examine the effect of CoAlation on the activity of modified proteins, our efforts were focused on SaGAPDH, a major target of S-thiolation in prokaryotic and eukaryotic cells in response to oxidative and metabolic stress. We provide evidence that CoAlation protects the catalytic cysteine in SaGAPDH against overoxidation under H~2~O~2~ stress *in vitro* and offers a reversible mode of regeneration of this essential glycolytic enzyme during the recovery from oxidative stress. Using MD simulations to examine the binding mode between CoA and SaGAPDH, we found that in the most stable conformation, the ADP moiety of CoA occupies the deep cavity where the nicotinamide-binding pocket is located, and the CoA thiol group and Cys151 are within the distance permitting covalent disulfide bond formation. Based on these findings and a recently reported crystal structure of overoxidized SaGAPDH which lacks NAD^+^ in the binding pocket, we propose a double anchor model for GAPDH CoAlation in response to oxidative or metabolic stress. In this model, the ADP moiety of CoA anchors to the nucleotide-binding pocket in the oxidized form of GAPDH and positions the CoA thiol group in the flexible pantetheine tail in close vicinity for covalent bond formation with catalytic Cys151 ([Figure 7B](#BCJ-475-1909F7){ref-type="fig"}).
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4PP

:   4′-phosphopantetheine

AhpC

:   alkyl hydroperoxide reductase C

CoA

:   coenzyme A

CoASSCoA

:   CoA disulfide

CoASSG

:   CoA-cysteine and CoA-glutathione

DTT

:   dithiothreitol

Fbp

:   fructose-1,6-bisphosphate aldolase

GapA2

:   glyceraldehyde-3-phosphate dehydrogenase 2

GAPDH

:   glyceraldehyde-3-phosphate dehydrogenase

GO

:   Gene Ontology

GSH

:   glutathione

GuaB

:   inosine-5′-monophosphate dehydrogenase

H~2~O~2~

:   hydrogen peroxide

HMG

:   3-hydroxy-3-methylglutaryl

HOCl

:   hypochlorous acid

IAM

:   iodoacetamide

IPTG

:   isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside

LB

:   Luria Bertani

LMW

:   low-molecular-weight

MD

:   molecular dynamics

Mqo1/2

:   malate : quinone oxidoreductases 1 and 2

NaOCl

:   sodium hypochlorite

NB3

:   Nutrient Broth 3

OD~600~

:   optical density at 600 nm

PAGE

:   polyacrylamide gel electrophoresis

PpaC

:   manganese-dependent inorganic pyrophosphatase

ROS

:   reactive oxygen species

SaGAPDH

:   *S. aureus* glyceraldehyde-3-phosphate dehydrogenase

SDS

:   sodium dodecyl sulfate

TpiA

:   triose phosphate isomerase

Tpx

:   thiol peroxidase
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